Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heidi Weiss

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
International Journal of Biochemistry and Molecular Biology|April 18, 2012
Hedgehog signaling activation in the development of squamous cell carcinoma and adenocarcinoma of esophagusLing Yang, Li-Shu Wang, Xiaoxin Luke Chen, et al.
Neuro-Oncology|May 27, 2014
Predicting the likelihood of an isocitrate dehydrogenase 1 or 2 mutation in diagnoses of infiltrative gliomaLi Chen, Zoya Voronovich, Kenneth Clark, et al.
Oncotarget|August 28, 2020
Post FDA approval analysis of 200 gallium-68 DOTATATE imaging: A retrospective analysis in neuroendocrine tumor patientsAman Chauhan, Riham El-Khouli, Timothy Waits, et al.
Journal of Virology|October 19, 2007
Identification of hexon-specific CD4 and CD8 T-cell epitopes for vaccine and immunotherapyAnn M Leen, Anne Christin, Mariam Khalil, et al.
Breast Cancer Research and Treatment|July 28, 2011
A phase II neoadjuvant trial of anastrozole, fulvestrant, and gefitinib in patients with newly diagnosed estrogen receptor positive breast cancerSuleiman Massarweh, Yee L Tham, Jian Huang, et al.
Breast Cancer Research and Treatment|November 20, 2009
Nuclear IRS-1 predicts tamoxifen response in patients with early breast cancerIlenia Migliaccio, Meng-Fen Wu, Carolina Gutierrez, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 24, 2004
Progesterone receptor by immunohistochemistry and clinical outcome in breast cancer: a validation studySyed K Mohsin, Heidi Weiss, Thomas Havighurst, et al.
Brain Research|February 20, 2022
Extracellular vesicles released after cranial radiation: An insight into an early mechanism of brain injurySuriyan Sukati, Jenni Ho, Luksana Chaiswing, et al.
Free Radical Biology & Medicine|December 6, 2024
Extracellular vesicles released by ALL patients contain HNE-adducted proteins: Implications of collateral damageJenni Ho, Suriyan Sukati, Tamara Taylor, et al.
Cells|June 2, 2021
PI3K/mTOR Dual Inhibitor PF-04691502 Is a Schedule-Dependent Radiosensitizer for Gastroenteropancreatic Neuroendocrine TumorsZeta Chow, Jeremy Johnson, Aman Chauhan, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
International Journal of Biochemistry and Molecular Biology|April 18, 2012
Hedgehog signaling activation in the development of squamous cell carcinoma and adenocarcinoma of esophagusLing Yang, Li-Shu Wang, Xiaoxin Luke Chen, et al.
Neuro-Oncology|May 27, 2014
Predicting the likelihood of an isocitrate dehydrogenase 1 or 2 mutation in diagnoses of infiltrative gliomaLi Chen, Zoya Voronovich, Kenneth Clark, et al.
Oncotarget|August 28, 2020
Post FDA approval analysis of 200 gallium-68 DOTATATE imaging: A retrospective analysis in neuroendocrine tumor patientsAman Chauhan, Riham El-Khouli, Timothy Waits, et al.
Journal of Virology|October 19, 2007
Identification of hexon-specific CD4 and CD8 T-cell epitopes for vaccine and immunotherapyAnn M Leen, Anne Christin, Mariam Khalil, et al.
Breast Cancer Research and Treatment|July 28, 2011
A phase II neoadjuvant trial of anastrozole, fulvestrant, and gefitinib in patients with newly diagnosed estrogen receptor positive breast cancerSuleiman Massarweh, Yee L Tham, Jian Huang, et al.
Breast Cancer Research and Treatment|November 20, 2009
Nuclear IRS-1 predicts tamoxifen response in patients with early breast cancerIlenia Migliaccio, Meng-Fen Wu, Carolina Gutierrez, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 24, 2004
Progesterone receptor by immunohistochemistry and clinical outcome in breast cancer: a validation studySyed K Mohsin, Heidi Weiss, Thomas Havighurst, et al.
Brain Research|February 20, 2022
Extracellular vesicles released after cranial radiation: An insight into an early mechanism of brain injurySuriyan Sukati, Jenni Ho, Luksana Chaiswing, et al.
Free Radical Biology & Medicine|December 6, 2024
Extracellular vesicles released by ALL patients contain HNE-adducted proteins: Implications of collateral damageJenni Ho, Suriyan Sukati, Tamara Taylor, et al.
Cells|June 2, 2021
PI3K/mTOR Dual Inhibitor PF-04691502 Is a Schedule-Dependent Radiosensitizer for Gastroenteropancreatic Neuroendocrine TumorsZeta Chow, Jeremy Johnson, Aman Chauhan, et al.
Pageof 6